Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
18 08 2020
Historique:
pubmed: 5 8 2020
medline: 7 10 2020
entrez: 5 8 2020
Statut: ppublish

Résumé

Medulloblastoma is the most common malignant brain tumor in children. Here we describe a medulloblastoma model using Induced pluripotent stem (iPS) cell-derived human neuroepithelial stem (NES) cells generated from a Gorlin syndrome patient carrying a germline mutation in the sonic hedgehog (SHH) receptor

Identifiants

pubmed: 32747535
pii: 1920521117
doi: 10.1073/pnas.1920521117
pmc: PMC7443968
doi:

Substances chimiques

Anilides 0
Galectin 1 0
Hedgehog Proteins 0
HhAntag691 0
PTCH1 protein, human 0
Patched-1 Receptor 0
Pyridines 0
SHH protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20127-20138

Subventions

Organisme : Wellcome Trust
ID : 201511/Z/16/Z
Pays : United Kingdom

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Cell. 2015 Apr 9;161(2):240-54
pubmed: 25860607
Nature. 2017 May 11;545(7653):229-233
pubmed: 28445466
Clin Cancer Res. 2015 Mar 15;21(6):1457-65
pubmed: 25344580
Cancer Res. 2008 Apr 1;68(7):2241-9
pubmed: 18381430
Stroke. 2009 Nov;40(11):3618-26
pubmed: 19762700
J Pathol. 2009 May;218(1):86-94
pubmed: 19197950
Cell Stem Cell. 2019 Sep 5;25(3):433-446.e7
pubmed: 31204176
Neuro Oncol. 2014 Jan;16(1):9-20
pubmed: 24305711
PLoS One. 2012;7(1):e29597
pubmed: 22272239
PLoS One. 2009;4(5):e5498
pubmed: 19430532
J Clin Oncol. 2015 Aug 20;33(24):2646-54
pubmed: 26169613
Mol Cell Neurosci. 2004 Dec;27(4):489-96
pubmed: 15555926
Annu Rev Pathol. 2008;3:341-65
pubmed: 18039127
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
pubmed: 28609654
Eur J Cancer. 2014 Sep;50(14):2463-77
pubmed: 25042151
Orphanet J Rare Dis. 2008 Nov 25;3:32
pubmed: 19032739
Oncogene. 2009 May 14;28(19):2015-23
pubmed: 19363525
Nat Rev Cancer. 2012 Dec;12(12):818-34
pubmed: 23175120
Cancer Cell. 2008 Aug 12;14(2):135-45
pubmed: 18691548
PLoS One. 2008 Aug 28;3(8):e3088
pubmed: 18769486
Nature. 2017 Jul 19;547(7663):311-317
pubmed: 28726821
Pediatr Blood Cancer. 2014 Jan;61(1):107-15
pubmed: 23940083
Mol Psychiatry. 2018 Jul;23(7):1674-1684
pubmed: 28924182
Cancer Cell. 2008 Aug 12;14(2):123-34
pubmed: 18691547
Acta Neuropathol. 2012 Apr;123(4):473-84
pubmed: 22358457
Acta Neuropathol. 2011 Mar;121(3):381-96
pubmed: 21267586
EMBO J. 2010 Aug 4;29(15):2646-58
pubmed: 20581804
Mol Carcinog. 2015 Jun;54(6):473-84
pubmed: 24285572
Cancer Res. 2006 Apr 15;66(8):4215-22
pubmed: 16618744
Nature. 2012 Aug 2;488(7409):43-8
pubmed: 22722829
Chin J Cancer. 2011 Jul;30(7):442-9
pubmed: 21718590
PLoS One. 2009;4(3):e4818
pubmed: 19287498
J Neurosci. 2013 Jul 24;33(30):12407-22
pubmed: 23884946
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12698-703
pubmed: 20616000
Cancer Cell. 2014 Jul 14;26(1):33-47
pubmed: 24954133
J Biotechnol. 2016 Oct 20;236:10-25
pubmed: 27498314
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Cell Death Discov. 2018 Feb 1;4:7
pubmed: 29531804
Chem Biol Interact. 2019 Jan 5;297:50-56
pubmed: 30365942
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
J Proteome Res. 2007 Feb;6(2):869-75
pubmed: 17269744
Int J Mol Sci. 2018 Feb 01;19(2):
pubmed: 29389859
Br J Dermatol. 2008 Aug;159(2):445-52
pubmed: 18510667
Nat Rev Drug Discov. 2008 Aug;7(8):659-66
pubmed: 18617887
Cancer. 2003 Aug 1;98(3):618-24
pubmed: 12879481
Cancer Res. 1997 Mar 1;57(5):842-5
pubmed: 9041183
Nature. 2010 Dec 23;468(7327):1095-9
pubmed: 21150899

Auteurs

Evelyn Susanto (E)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Ana Marin Navarro (A)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Leilei Zhou (L)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Anders Sundström (A)

Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden.

Niek van Bree (N)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Marina Stantic (M)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Mohsen Moslem (M)

Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden.

Jignesh Tailor (J)

Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada.
Division of Neurosurgery, University of Toronto, Toronto, ON M5S 1A8, Canada.

Jonne Rietdijk (J)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Veronica Zubillaga (V)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Jens-Martin Hübner (JM)

Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Research Consortium (DKTK), 69120 Heidelberg, Germany.

Holger Weishaupt (H)

Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden.

Johanna Wolfsberger (J)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden.

Irina Alafuzoff (I)

Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden.

Ann Nordgren (A)

Department of Molecular Medicine and Surgery, Center for Molecular Medicine, Karolinska Institutet, 171 76 Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, 171 76 Stockholm, Sweden.

Thierry Magnaldo (T)

Institute for Research on Cancer and Aging, CNRS UMR 7284, INSERM U1081, University of Nice Sophia Antipolis, Nice, France.

Peter Siesjö (P)

Division of Neurosurgery, Department of Clinical Sciences, Skane University Hospital, 221 85 Lund, Sweden.
Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden.

John Inge Johnsen (JI)

Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden.

Marcel Kool (M)

Hopp Children's Cancer Center (KiTZ), 69120 Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), and German Cancer Research Consortium (DKTK), 69120 Heidelberg, Germany.

Kristiina Tammimies (K)

Department of Women's and Children's Health, Karolinska Institutet, 171 76 Stockholm, Sweden.

Anna Darabi (A)

Glioma Immunotherapy Group, Division of Neurosurgery, Department of Clinical Sciences, Lund University, 221 85 Lund, Sweden.

Fredrik J Swartling (FJ)

Department of Immunology, Genetics, and Pathology, Science For Life Laboratory, Uppsala University, 751 85 Uppsala, Sweden.

Anna Falk (A)

Department of Neuroscience, Karolinska Institutet, 171 65 Stockholm, Sweden; margareta.wilhelm@ki.se anna.falk@ki.se.

Margareta Wilhelm (M)

Department of Microbiology, Tumor and Cell biology (MTC), Karolinska Institutet, 171 65 Stockholm, Sweden; margareta.wilhelm@ki.se anna.falk@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH